GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 14 filers reported holding GAMIDA CELL LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,079 | -46.6% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $56,362 | +138.3% | 29,203 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $23,654 | -37.2% | 29,203 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $37,672 | -24.7% | 29,203 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $50,000 | -3.8% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -57.0% | 29,203 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $121,000 | +63.5% | 29,203 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $74,000 | -35.1% | 29,203 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $114,000 | -51.7% | 29,203 | 0.0% | 0.00% | -60.0% |
Q1 2021 | $236,000 | -36.2% | 29,203 | -33.9% | 0.01% | -50.0% |
Q4 2020 | $370,000 | +58.8% | 44,203 | -25.3% | 0.01% | 0.0% |
Q3 2020 | $233,000 | -8.3% | 59,203 | 0.0% | 0.01% | -9.1% |
Q2 2020 | $254,000 | +195.3% | 59,203 | +102.7% | 0.01% | +175.0% |
Q1 2020 | $86,000 | -31.2% | 29,203 | 0.0% | 0.00% | -20.0% |
Q4 2019 | $125,000 | +3.3% | 29,203 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $121,000 | – | 29,203 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |